91̽»¨

University 91̽»¨
  2. About
  3. Find staff
  4. Diana Swolin-Eide

Diana Swolin-Eide

Professor/ Chief Physician

Department of Pediatrics
Telephone
+46 722-05 03 91
Mail
diana.swolin-eide@gu.se
Visiting address
Drottning Silvias barnsjukhus, Behandlingsvägen 7, plan1
416 85 Göteborg
Postal address
Inst f kliniska vetenskaper, Drottning Silvias barnsjukhus, Behandlingsvägen 7
416 85 Göteborg

About Diana Swolin-Eide

§ Professor at the Department of Pediatrics, Sahlgrenska Academy at the University 91̽»¨, Sweden.

§ University Hospital Chief Physician at Pediatric Endocrinology at Queen Silvia's Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.

§ Head of Research and Education at Sahlgrenska University Hospital, Gothenburg, Sweden.

The research profile is growth, skeletal development in children and adolescents, osteoporosis and bone density measurements. Diana Swolin-Eide defended her thesis in 1997 at the University 91̽»¨ with the thesis "Effects of Growth Hormone and Steroids in Human Osteoblast-like Cells" and became Associate Professor in Pediatrics in 2011 and Professor in 2021.

As Professor of pediatrics, Diana Swolin-Eide is responsible for the pediatric part of the Medical Program in Semester 9 and is a course leader and regularly participates in the Semester 9 Council, Pediatrics Council, Program Board and the Medical Program Committee.

RESEARCH

The majority of research projects are ongoing with doctoral students, students and external partners. Holders of external research funds and ALF funds. The overall aim is to study the regulation of bone density and growth in pediatric patients through translational studies with the goal of preventing growth disorders, osteoporosis and fractures. The projects have a unique profile within pediatric research in a field that is in increasing clinical demand, due to new patient groups. Osteoporosis is a nationally growing health problem with large costs to society. Many factors affect the skeleton and therefore several of these are studied.

Research profile

Osteoporosis and Type 1 diabetes are nationally growing health problems. The goal is to study bone density and growth in pediatric patients through clinical and translational studies. The goal is to increase knowledge about bone health, find early diagnosis, prevent growth disorders, reduce osteoporosis and change care programs within a few years. High clinical competence is found in our multidisciplinary research group and a functional infrastructure.

Diana has been working for a long time with medical educational issues at various levels and worked both locally, regionally and nationally with this type of issue.

Diabetes & bones

Type 1 diabetes is the second most common disease in children in Sweden and the incidence has increased. In our SweBoneDiab study and the 5-year longitudinal follow-up, young people with long diabetes duration are examined regarding growth, bone density, bone microstructure, bone markers and body composition. A unique control group is available and metabolic data from national registries are available. Preventing diabetes complications is one of the goals.

Micro-RNA & bones

Micro-RNA affects gene expression and proteins and their relationship to the skeleton and type 1 diabetes in young people is unknown. In SweBoneDiab and in the longitudinal study, miRNA will be studied in relation to other data collected in an international study. Are there differences between young individuals with diabetes and healthy young people? Our pilot study shows a relationship to cancer and this will be validated. Potential to become new clinical markers.

Growth & Bone

The goal is to study early growth patterns and growth in diseases such as diabetes. Models that explain the different phases of growth will be used. Different clinical cohorts will be used. The growth and bone health of young kidney transplant patients will be followed up to 10 years after transplantation. Bone health will increase and long-term follow-up of prematurely born children is clinically important.

Rare skeletal diseases

Clinical pediatric skeletal dysplasias will be diagnosed using various genetic analyses, which will contribute to increased knowledge and will be valuable when SU applies for NHV assignments. The studies will lead to improved treatment, rehabilitation and quality of life in young patients.

Ongoing doctoral projects:

Specialist physician Carin Skogastierna: "Studies of early growth in childhood".

Specialist physician Erik Myrberg: "Peer coaching as a method for developing physicians' competence as clinical supervisors".

Several individuals conduct research with Diana as a supervisor, such as master's students as well as Associate professors in molecular and clinical medicine.

OTHER

Member of the Majblomman Research Council and the Ã…grenska Board. Member on the steering committee for the education program for Innovation and Technology and the Emergency Preparedness and Disaster Medicine program for doctors. Many other assignments exists within a broad area of Educational boards and programs.

Watch the film from GU Play: New professor in 2021

Diana Swolin-Eide, Professor of Pediatrics